BioSpace News Archive

Second Genome announced they are entering a strategic collaboration with Arena Pharmaceuticals, Inc. to identify microbiome biomarkers associated with clinical response for their lead program in gastroenterology, etrasimod.

Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, reported financial results for the second quarter ended June 30, 2021 and provided recent corporate updates.

Enanta Pharmaceuticals, Inc., a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced the nomination of EDP-235, its lead oral protease inhibitor specifically designed for the treatment of COVID-19.

Takeda Pharmaceutical Company Limited announced the publication of the final results from the Phase 3 HELP Study™ Open-label Extension designed to evaluate the long-term safety and efficacy of TAKHZYRO® 300mg every two weeks for up to 2.5 years.

Castle Biosciences, Inc., a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, announced data presentations on two of its skin cancer gene expression profile tests at the DEF Essential Resource Meeting NP/PA CME Conference, taking place from Aug. 5-8, 2021.

Authors studied lab results for 28 million Americans with the highest risk and found most are not getting recommended tests to detect life-threatening disease

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, reported financial results for the second quarter ended June 30, 2021, and provided a business update.

Wave Life Sciences Ltd. today announced financial results for the second quarter ended June 30, 2021 and provided a business update.

Phathom Pharmaceuticals, Inc. announced today the sad news that its chairman and founder, Dr. Tachi Yamada, passed away suddenly at his Seattle, Washington home on August 4.

Strongbridge Biopharma plc, today reported financial results for the second quarter of 2021 and provided a corporate update.